Americans With ALS Look to Canada for Promising Drug the U.S. Hasn’t Approved
Share this @internewscast.com



Canada approved Amylyx Pharmaceuticals Inc.’s new drug for amyotrophic lateral sclerosis last week. Now some U.S. patients with the fatal neurodegenerative disorder—also known as Lou Gehrig’s disease—are considering a trip north to get the medication, Albrioza. The drug isn’t approved in the U.S.

William Woods, a 75-year-old retired doctor in Atlanta who was diagnosed with ALS in 2019, is contacting Canadian doctors who might help him get Albrioza. “There is a lot to figure out,” he said, “but I am confident I will find somebody I can go see.”

Share this @internewscast.com
You May Also Like

Justice Department Opposes Unsealing Trump’s Mar-A-Lago Search Warrant Affidavit

Topline The Justice Department on Monday asked a federal judge to not…

Coin Center may challenge US Treasury’s sanctions on Tornado Cash in court

United States-based crypto policy advocacy group Coin Center said it intended to…

Washington Commanders Just Inked Their Richest Sponsorship Deal Ever

Taylor Heinicke #4 of the Washington Football Team celebrates after defeating the…

Fed Officials Pledge More Big Rate Hikes Until There Is A ‘Meaningful’ Decline In Inflation

Topline The Federal Reserve reaffirmed that it is unlikely to take its…

Social Security Blows It Once Again, But, With My Company’s Help, Ultimately Redeems Itself

Puzzle getty Here’s a description from Emily (not her real name) of…

If You’re Struggling to Solve a Problem, You May Be Looking at Things Just 1% Wrong

This article is excerpted from the new book Build for Tomorrow. We…

Russian Navy Crews Are Under Orders To Avoid The Ukrainian Coast

‘Moskva’ burns on April 13, 2022. Photo via social media The commanders…

Amazon’s ‘Thursday Night Football’ Coverage to Be Tracked by Nielsen

Amazon Inc. has struck a deal with Nielsen Holdings PLC to have…